Gene therapy

In T1D, islets are the target for autoreactive T cell destruction. The absence of islets leads to insulin deficiencies and resultant hyperglycemia. Gene therapy is a useful technique to treat T1D as it can be applied from many different angles. The insulin gene can be replaced in a host or the autoreactive T cells suppressed.

    Related Conference of Gene therapy

    June 20-21, 2018

    27th European Diabetes Congress

    | Rome, Italy
    July 16-17, 2018 Sydney, Australia

    20th Asia Pacific Diabetes Conference

    July 23-24, 2018

    Global Meeting on Diabetes and Endocrinology

    Kuala Lumpur, Malaysia
    August 20-21, 2018

    28th World Congress on Diabetes, Obesity & Heart

    Tokyo, Japan
    September 03-04, 2018

    2nd International Conference on Thyroid and Pregnancy

    Auckland, New Zealand
    September 3-4, 2018

    11th World Congress on Endocrinology and Metabolic Disorders

    Auckland, New Zealand
    September 13-15, 2018

    26th International Diabetes and Healthcare Conference

    Bucharest, Romania
    Sep 14-15, 2018

    World Congress on Endocrinology

    Prague , Czech Republic
    Sep 14-15, 2018

    Euro Diabetes Congress & Expo

    | Prague, Czech Republic
    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    Gene therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in